ScoreWhy is Anuh Pharma Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of 12.30% and Operating profit at 11.02% over the last 5 years
2
Flat results in Mar 26
- ROCE(HY) Lowest at 15.53%
3
Stock is technically in a Bearish range
- The technical trend has deteriorated from Mildly Bearish on 21-May-26
- Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
4
Despite the size of the company, domestic mutual funds hold only 0% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
5
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 0.10% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -24.46% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Anuh Pharma for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Anuh Pharma
-23.11%
-0.69
35.69%
Sensex
-5.06%
-0.49
12.94%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
12.30%
EBIT Growth (5y)
11.02%
EBIT to Interest (avg)
49.00
Debt to EBITDA (avg)
0.24
Net Debt to Equity (avg)
-0.15
Sales to Capital Employed (avg)
2.12
Tax Ratio
24.31%
Dividend Payout Ratio
15.87%
Pledged Shares
0
Institutional Holding
0.05%
ROCE (avg)
19.55%
ROE (avg)
15.22%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
20
Industry P/E
34
Price to Book Value
2.29
EV to EBIT
15.15
EV to EBITDA
12.33
EV to Capital Employed
2.52
EV to Sales
0.98
PEG Ratio
NA
Dividend Yield
1.86%
ROCE (Latest)
16.65%
ROE (Latest)
11.65%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
NET SALES(Q)
Highest at Rs 202.12 cr
PBDIT(Q)
Highest at Rs 19.88 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 9.84%
PBT LESS OI(Q)
Highest at Rs 16.77 cr.
-3What is not working for the Company
ROCE(HY)
Lowest at 15.53%
Loading Valuation Snapshot...
Here's what is working for Anuh Pharma
Net Sales - Quarterly
Highest at Rs 202.12 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 19.88 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 9.84%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 16.77 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
